Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated:  10/17/2017
NorthShore University HealthSystem-Glenbrook Hospital
mi
from
Glenview, IL
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
NorthShore University HealthSystem-Glenbrook Hospital
mi
from
Glenview, IL
Click here to add this to my saved trials
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated:  10/17/2017
Sportsmed Sa
mi
from
Stepney,
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Sportsmed Sa
mi
from
Stepney,
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Peoria, AZ
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Peoria, AZ
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Palm Desert, CA
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Palm Desert, CA
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Boca Raton, FL
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Brandon, FL
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Brandon, FL
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Jacksonville, FL
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Miami Lakes, FL
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Miami, FL
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Sarasota, FL
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Shreveport, LA
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Lansing, MI
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Lansing, MI
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Durham, NC
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Middleburg Heights, OH
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Duncansville, PA
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Amarillo, TX
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Amarillo, TX
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Austin, TX
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Mesquite, TX
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Mesquite, TX
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
mi
from
Plovdiv,
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
mi
from
Plovdiv,
Click here to add this to my saved trials
Weight-Bearing Tomosynthesis In Evaluation of Foot/AnkIe
Weight-Bearing Tomosynthesis In Evaluation of Foot/AnkIe
Status: Enrolling
Updated:  10/24/2017
Univ of Washington
mi
from
Seattle, WA
Weight-Bearing Tomosynthesis In Evaluation of Foot/AnkIe
Weight-Bearing Tomosynthesis In Evaluation of Foot/AnkIe
Status: Enrolling
Updated: 10/24/2017
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Evaluation of Amniotic Fluid Product in Knee Osteoarthritis
Protocol for the Clinical Evaluation Amniotic Fluid (AF) Product in Knee Osteoarthritis
Status: Enrolling
Updated:  10/25/2017
Central Research Associates, Inc
mi
from
Birmingham, AL
Evaluation of Amniotic Fluid Product in Knee Osteoarthritis
Protocol for the Clinical Evaluation Amniotic Fluid (AF) Product in Knee Osteoarthritis
Status: Enrolling
Updated: 10/25/2017
Central Research Associates, Inc
mi
from
Birmingham, AL
Click here to add this to my saved trials
Evaluation of Amniotic Fluid Product in Knee Osteoarthritis
Protocol for the Clinical Evaluation Amniotic Fluid (AF) Product in Knee Osteoarthritis
Status: Enrolling
Updated:  10/25/2017
Weil Foot, Ankle and Orthopedic Institute
mi
from
Des Plaines, IL
Evaluation of Amniotic Fluid Product in Knee Osteoarthritis
Protocol for the Clinical Evaluation Amniotic Fluid (AF) Product in Knee Osteoarthritis
Status: Enrolling
Updated: 10/25/2017
Weil Foot, Ankle and Orthopedic Institute
mi
from
Des Plaines, IL
Click here to add this to my saved trials
Sleep and Immunity in Rheumatoid Arthritis : Remicade Substudy
Sleep & Immune Mechanisms in Rheumatoid Arthritis: Remicade Substudy
Status: Enrolling
Updated:  10/26/2017
University of California, Los Angeles, General Clinical Research Center
mi
from
Los Angeles, CA
Sleep and Immunity in Rheumatoid Arthritis : Remicade Substudy
Sleep & Immune Mechanisms in Rheumatoid Arthritis: Remicade Substudy
Status: Enrolling
Updated: 10/26/2017
University of California, Los Angeles, General Clinical Research Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Does Fluid Replacement From Preoperative NPO Status Improve Postoperative Recovery
Does Fluid Replacement From Preoperative NPO Status Improve Postoperative Recovery and Reduce Complications in Arthroplasty Patients?
Status: Enrolling
Updated:  10/26/2017
WVU Medicine Department of Orthopaedics
mi
from
Morgantown, WV
Does Fluid Replacement From Preoperative NPO Status Improve Postoperative Recovery
Does Fluid Replacement From Preoperative NPO Status Improve Postoperative Recovery and Reduce Complications in Arthroplasty Patients?
Status: Enrolling
Updated: 10/26/2017
WVU Medicine Department of Orthopaedics
mi
from
Morgantown, WV
Click here to add this to my saved trials
High Intensity Interval Training in Osteoarthritis, Effects on Metabolomics
Feasibility and Initial Effects of High Intensity Interval Training on Knee Osteoarthritis: an Exploratory Evaluation on Metabolomics
Status: Enrolling
Updated:  10/27/2017
Applied Physiology Laboratory
mi
from
Chapel Hill, NC
High Intensity Interval Training in Osteoarthritis, Effects on Metabolomics
Feasibility and Initial Effects of High Intensity Interval Training on Knee Osteoarthritis: an Exploratory Evaluation on Metabolomics
Status: Enrolling
Updated: 10/27/2017
Applied Physiology Laboratory
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Strength Training for ARthritis Trial
Strength Training for ARthritis Trial
Status: Enrolling
Updated:  11/2/2017
Wake Forest University
mi
from
Winston-Salem, NC
Strength Training for ARthritis Trial
Strength Training for ARthritis Trial
Status: Enrolling
Updated: 11/2/2017
Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Intensive Diet and Exercise for Improving Knee Osteoarthritis in Obese and Overweight Older Adults
Intensive Diet and Exercise for Arthritis
Status: Enrolling
Updated:  11/2/2017
Wake Forest University/Wake Forest University Forest School of Medicine
mi
from
Winston-Salem, NC
Intensive Diet and Exercise for Improving Knee Osteoarthritis in Obese and Overweight Older Adults
Intensive Diet and Exercise for Arthritis
Status: Enrolling
Updated: 11/2/2017
Wake Forest University/Wake Forest University Forest School of Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Real-world Clinical Efficacy of Abatacept in the T3 Data Registry
Abatacept in T3: A Characterization of Abatacept's Efficacy and Outcomes From a Real-Word Clinical Practice Information Hub on Novel Patient Sub-Groups
Status: Enrolling
Updated:  11/2/2017
Arthritis Northwest
mi
from
Spokane, WA
Real-world Clinical Efficacy of Abatacept in the T3 Data Registry
Abatacept in T3: A Characterization of Abatacept's Efficacy and Outcomes From a Real-Word Clinical Practice Information Hub on Novel Patient Sub-Groups
Status: Enrolling
Updated: 11/2/2017
Arthritis Northwest
mi
from
Spokane, WA
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Glendale, AZ
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Glendale, AZ
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Peoria, AZ
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Peoria, AZ
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Phoenix, AZ
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Tucson, AZ
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Fresno, CA
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
La Jolla, CA
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Palm Desert, CA
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Palm Desert, CA
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Santa Maria, CA
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Santa Maria, CA
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Upland, CA
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Upland, CA
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Boulder, CO
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Boulder, CO
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Denver, CO
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Danbury, CT
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Danbury, CT
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Trumbull, CT
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Trumbull, CT
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Lewes, DE
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Lewes, DE
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Boynton Beach, FL
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Naples, FL
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Naples, FL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
New Port Richey, FL
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
New Port Richey, FL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Orlando, FL
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Palm Harbor, FL
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Tampa, FL
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Vernon Hills, IL
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Vernon Hills, IL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
mi
from
Indianapolis, IN
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials